Related Experiment Video

Updated: Aug 17, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

[Percutaneous coronary intervention combined cardiac resynchronization therapy for refractory heart failure secondary

Ya-ling Han1, Hong-yun Zang, Dong-mei Wang

  • 1Department of Cardiology, Shenyang General Hospital of PLA, Shenyang 110016, China.

Zhonghua Xin Xue Guan Bing Za Zhi
|June 1, 2005
PubMed

Insights

Percutaneous coronary intervention (PCI) combined with cardiac resynchronization therapy (CRT) significantly improves heart function and quality of life in patients with refractory ischemic cardiomyopathy (ICM). This combined therapy offers a safe and effective treatment option for advanced heart failure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Management

Context:

  • Ischemic cardiomyopathy (ICM) frequently leads to refractory heart failure.
  • Current treatment options for advanced ICM heart failure have limitations.
  • Percutaneous coronary intervention (PCI) and cardiac resynchronization therapy (CRT) are established treatments for specific aspects of cardiovascular disease.

Purpose:

  • To assess the efficacy and safety of combining PCI with CRT in patients suffering from refractory heart failure due to ICM.
  • To evaluate the impact of this combined therapeutic approach on cardiac function, clinical status, and long-term outcomes.

Summary:

  • Seven patients with severe ICM and refractory heart failure underwent combined PCI and CRT.
  • All procedures were successful, with various pacing configurations utilized.
  • Significant improvements were observed in New York Heart Association class, 6-minute walking distance, mitral regurgitation, and QRS duration.
  • Left ventricular dimensions and ejection fraction showed notable improvement in select patients.

Impact:

  • Combined PCI and CRT demonstrates a significant positive impact on heart function, quality of life, and prognosis for refractory heart failure in ICM.
  • The combination therapy appears to be safe, with a low mortality rate and manageable complications.
  • This approach offers a promising therapeutic strategy for a challenging patient population.
Abstract

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...